This acquisition follows Innophos’s acquisition of mineral ingredients supplier Kelatron Corp. this past November.
Phosphates specialist Innophos Holdings Inc. (Cranbury, NJ), parent company of Innophos Inc., has acquired mineral ingredients firm AMT Labs Inc. (North Salt Lake, UT) for $27 million, the firm announced. This acquisition follows Innophos’s $21 million acquisition of mineral ingredients supplier Kelatron Corp. (Ogden, UT) this past November.
Privately held firm AMT Labs specializes in producing mineral ingredients in various bioavailable forms, including chelates, and ascorbates and citrates.
“AMT is highly complementary to the Kelatron business acquired by Innophos in November 2011,” Innophos stated in a press release. “The combined businesses of Kelatron and AMT make Innophos a leader in high-growth U.S. bioactive mineral ingredients, with annualized revenues approximating $30 million.”
Randy Gress, Innophos chairman and CEO, continued, “The acquisition of AMT represents the second step in our adjacency strategy to expand in product categories closely related to our existing specialty phosphate product line. AMT’s strengths are highly complementary to our new bioactive mineral ingredients business platform, providing high-quality manufacturing facilities better able to support the future growth expected in this product range.”
The Nutritional Outlook Podcast Episode 29: 2024 Ingredients to Watch
January 31st 2024Nutritional Outlook interviews Scott Dicker, market insights director from market researcher SPINS, about ingredients and product categories nutraceutical and nutrition product manufacturers should watch in 2024.
The Link Between Immune Health Benefits & Healthy, Active Lifestyles
January 11th 2024Better immune health means more healthy, active days – and who doesn’t want that? Now, we’re in an era where consumers want to be proactive about their immune health. Nutritional Outlook’s latest podcast highlights one key immune health ingredient, IMMUSE™, that brings a unique mode of action to activate pDCs (plasmacytoid dendritic cells)* — a pivotal leader within the immune system.